Editorial

  • HOME
  • ARTICLE CATEGORY
  • Editorial
Editorial
New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
Young-Suk Lim
Clin Mol Hepatol. 2023;29(1):118-119.   Published online November 29, 2022
View: 417   Download: 56
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Clin Mol Hepatol. 2023;29(1):113-117.   Published online October 31, 2022
View: 638   Download: 45  Citation: 1
Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Susana G Rodrigues
Clin Mol Hepatol. 2023;29(1):110-112.   Published online December 12, 2022
View: 511   Download: 36
1730
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clin Mol Hepatol. 2023;29(1):105-109.   Published online November 23, 2022
View: 586   Download: 45  Citation: 1
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
Jeong-Ju Yoo, Sang Gyune Kim
Clin Mol Hepatol. 2023;29(1):102-104.   Published online November 10, 2022
View: 552   Download: 69
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(1):99-101.   Published online October 27, 2022
View: 602   Download: 31
Surveillance for hepatocellular carcinoma: It is time to move forward
Bo Hyun Kim, Yuri Cho, Joong-Won Park
Clin Mol Hepatol. 2022;28(4):810-813.   Published online September 6, 2022
View: 959   Download: 57  Citation: 1
1701
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):806-809.   Published online August 19, 2022
View: 948   Download: 37
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
Byoung Seok Ye
Clin Mol Hepatol. 2022;28(3):481-482.   Published online May 16, 2022
View: 1362   Download: 51
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Seonghwan Hwang, Won Kim
Clin Mol Hepatol. 2022;28(3):478-480.   Published online June 16, 2022
View: 1478   Download: 52
1687
Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?
Qian Jin, Rui-Xu Yang, Jian-Gao Fan
Clin Mol Hepatol. 2022;28(3):473-477.   Published online June 22, 2022
View: 1518   Download: 63  Citation: 1
Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
Hung-Yao Lin, Tai-Chung Tseng
Clin Mol Hepatol. 2022;28(2):181-182.   Published online February 21, 2022
View: 1739   Download: 85
1628
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
Takumi Kawaguchi, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):177-180.   Published online August 26, 2021
View: 2488   Download: 119
Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
Bo Hyun Kim
Clin Mol Hepatol. 2022;28(2):174-176.   Published online January 26, 2022
View: 1828   Download: 81
Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
Ja-Young Kwon
Clin Mol Hepatol. 2022;28(1):50-51.   Published online November 22, 2021
View: 2045   Download: 74
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Seung Mi Lee, Won Kim
Clin Mol Hepatol. 2022;28(1):47-49.   Published online November 30, 2021
View: 2185   Download: 79  Citations: 2
Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
Jong Man Kim
Clin Mol Hepatol. 2021;27(4):562-563.   Published online September 23, 2021
View: 2229   Download: 104  Citation: 1
Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
Ho Soo Chun, Minjong Lee
Clin Mol Hepatol. 2021;27(3):448-450.   Published online June 23, 2021
View: 2359   Download: 99
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Dae Won Jun
Clin Mol Hepatol. 2021;27(3):446-447.   Published online May 21, 2021
View: 2641   Download: 124
Another oral antiviral treatment, but still far away from hepatitis B virus cure
Tai-Chung Tseng
Clin Mol Hepatol. 2021;27(2):281-282.   Published online March 10, 2021
View: 2286   Download: 94  Citations: 2
Biopsy or cytology for diagnosing hepatic focal lesions?
Haeryoung Kim
Clin Mol Hepatol. 2021;27(2):278-280.   Published online March 4, 2021
View: 2113   Download: 59
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2021;27(2):273-277.   Published online February 1, 2021
View: 2713   Download: 114  Citations: 2
A need for patient-centered care in managing patients with liver cirrhosis
Eileen L. Yoon
Clin Mol Hepatol. 2021;27(2):270-272.   Published online January 27, 2021
View: 2165   Download: 87  Citation: 1
Old hepatitis B virus never dies: It just hides itself within the host genome
Jeong-Hoon Lee
Clin Mol Hepatol. 2021;27(1):107-109.   Published online December 23, 2020
View: 2414   Download: 103  Citations: 2
Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma
Jun Won Kim, Ik Jae Lee
Clin Mol Hepatol. 2021;27(1):103-106.   Published online December 14, 2020
View: 2337   Download: 87
Elimination of hepatitis C: What would be the practical approach?
Hyung Joon Yim
Clin Mol Hepatol. 2021;27(1):97-99.   Published online December 3, 2020
View: 3209   Download: 99  Citations: 2
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2021;27(1):94-96.   Published online December 3, 2020
View: 2643   Download: 111  Citations: 2

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1247
TOTAL : 1128369
Close layer